A Phase 1, Randomized, Open-Label, Crossover Study in Healthy Adult Male Subjects to Assess the Relative Bioavailability of Lesinurad Tablets Manufactured at Two Different Sites
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2014
Price : $35 *
At a glance
- Drugs Lesinurad (Primary)
- Indications Gout
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 21 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 Feb 2014 Planned End Date changed from 1 Feb 2014 to 1 May 2014 as reported by ClinicalTrials.gov record.
- 08 Jan 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.